Knapp Jeffrey H 4

4 · AFFYMAX INC · Filed Feb 19, 2013

Form 4

Period: 2013-02-15

Chief Commercial Officer

Transactions

Sale
Common Stock
2013-02-15$15.76/sh−2,328$36,686→ 18,125 total
Exercise/Conversion
Common Stock
2013-02-15$7.99/sh+1,000$7,990→ 19,125 total
Exercise/Conversion
Common Stock
2013-02-15$6.23/sh+1,015$6,323→ 20,453 total
Exercise/Conversion
Common Stock
2013-02-15$7.04/sh+313$2,204→ 19,438 total
Exercise/Conversion
Stock Option (Right to Buy)
2013-02-15−1,000→ 13,250 total
Exercise: $7.99Exp: 2022-01-30→ Common Stock (1,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2013-02-15−1,015→ 18,282 total
Exercise: $6.23Exp: 2020-07-21→ Common Stock (1,015 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2013-02-15−313→ 9,375 total
Exercise: $7.04Exp: 2021-07-10→ Common Stock (313 underlying)

Footnotes (5)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
[F2]The shares were sold at prices ranging from $15.72 to $15.79. The reporting person will provide to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F3]The award vests on a monthly basis in equal installments during the 48 month period beginning on January 1, 2012.
[F4]The award vests on a monthly basis in equal installments during the 48 month period beginning on July 11, 2011.
[F5]The award vests on a monthly basis in equal installments during the 48 month period beginning on July 22, 2010.

Documents

1 file